##  [New analysis shows Novartis Entresto improves glycemic control in reduced ejection fraction heart failure patients with diabetes](/us-en/news/media-releases/new-analysis-shows-novartis-entresto-improves-glycemic-control-reduced-ejection-fraction-heart-failure-patients-diabetes-0 "New analysis shows Novartis Entresto improves glycemic control in reduced ejection fraction heart failure patients with diabetes") 

  Mar 18, 2017